In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more.
Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more.
Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic - p. 491 9. The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer? - p. 501 10. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter? - p. 511 11. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment - p. 525 12. Obesity in Heart Failure with Reduced Ejection Fraction: Time to Address the Elephant in the Room - p. 537 13. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making? - p. 545 14. The War Against Heart Failure Hospitalizations: Remote Monitoring and the Case for Expanding Criteria - p. 557 15. Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction? - p. 575 16. Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely - p. 583 17. When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device - p. 593
In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more.
Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more.
Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic - p. 491 9. The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer? - p. 501 10. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter? - p. 511 11. Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment - p. 525 12. Obesity in Heart Failure with Reduced Ejection Fraction: Time to Address the Elephant in the Room - p. 537 13. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making? - p. 545 14. The War Against Heart Failure Hospitalizations: Remote Monitoring and the Case for Expanding Criteria - p. 557 15. Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction? - p. 575 16. Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely - p. 583 17. When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device - p. 593
